SAFETY AND EFFICACY OF TISAGENLECLEUCEL PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: UPDATED ANALYSIS OF THE PHASE 1B PORTIA STUDY

U. Jaeger; N. Worel; J. P. McGuirk; P. A. Riedell; I. Fleury; P. Borchmann; Y. Du; A. M. Abdelhady; X. Han; M. Martinez‐Prieto; E. K. Waller

doi:10.1002/hon.179_2880

SAFETY AND EFFICACY OF TISAGENLECLEUCEL PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: UPDATED ANALYSIS OF THE PHASE 1B PORTIA STUDY

Hematological Oncology ◽

10.1002/hon.179_2880 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

U. Jaeger ◽

N. Worel ◽

J. P. McGuirk ◽

P. A. Riedell ◽

I. Fleury ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Phase 1B ◽

Large B Cell

Download Full-text

Abstract CT162: The phase 1b PORTIA study: Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL)

10.1158/1538-7445.am2020-ct162 ◽

2020 ◽

Author(s):

Ulrich Jaeger ◽

Nina Worel ◽

Joseph P. McGuirk ◽

Peter A. Riedell ◽

Isabelle Fleury ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Phase 1B ◽

Large B Cell

Download Full-text

A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination with Tremelimumab or Danvatirsen in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2020.12.012 ◽

2020 ◽

Author(s):

Vincent Ribrag ◽

Seung Tae Lee ◽

David Rizzieri ◽

Martin JS. Dyer ◽

Luis Fayad ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Phase 1B ◽

Large B Cell

Download Full-text

PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

Hematological Oncology ◽

10.1002/hon.7_2632 ◽

2019 ◽

Vol 37 ◽

pp. 560-560

Author(s):

U. Jaeger ◽

J. McGuirk ◽

N. Worel ◽

P. Riedell ◽

I. Fleury ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Phase 1B ◽

Large B Cell

Download Full-text

A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Case Medical Research ◽

10.31525/ct1-nct04182204 ◽

2019 ◽

Author(s):

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma

Case Medical Research ◽

10.31525/ct1-nct04250324 ◽

2020 ◽

Author(s):

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Safety and efficacy of GVD and anti-PD-1 (SHR-1210) regimen with or without low-dose decitabine priming for refractory bulky and aggressive primary mediastinal large B-cell lymphoma.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.7556 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 7556-7556 ◽

Cited By ~ 2

Author(s):

Wenying Zhang ◽

Yang Liu ◽

Qian Mei ◽

Lianjun Shen ◽

Qingming Yang ◽

...

Keyword(s):

B Cell ◽

Low Dose ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Safety and efficacy of CHOP for treatment of diffuse large B-cell lymphoma with different cART regimens: SCULPT study

Antiviral Therapy ◽

10.3851/imp2572 ◽

2013 ◽

Vol 18 (5) ◽

pp. 699-707 ◽

Cited By ~ 6

Author(s):

Alison YJ Wong ◽

Suzanne Marcotte ◽

Mathieu Laroche ◽

Nancy L Sheehan ◽

Vishal Kukreti ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

SAFETY AND CLINICAL ACTIVITY OF ATEZOLIZUMAB IN COMBINATION WITH TAZEMETOSTAT IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 1B STUDY

Hematological Oncology ◽

10.1002/hon.203_2631 ◽

2019 ◽

Vol 37 ◽

pp. 517-519 ◽

Cited By ~ 1

Author(s):

M.L. Palomba ◽

G. Cartron ◽

L. Popplewell ◽

V. Ribrag ◽

J. Westin ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Clinical Activity ◽

Primary Analysis ◽

Large B Cell Lymphoma ◽

Phase 1B ◽

Large B Cell

Download Full-text

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study

The Lancet Oncology ◽

10.1016/s1470-2045(19)30091-9 ◽

2019 ◽

Vol 20 (7) ◽

pp. 998-1010 ◽

Cited By ~ 41

Author(s):

Hervé Tilly ◽

Franck Morschhauser ◽

Nancy L Bartlett ◽

Amitkumar Mehta ◽

Gilles Salles ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Open Label ◽

Large B Cell Lymphoma ◽

Phase 1B ◽

Large B Cell

Download Full-text

Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b Study

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2021.12.010 ◽

2021 ◽

Author(s):

M. Lia Palomba ◽

Brian G. Till ◽

Steven I. Park ◽

Franck Morschhauser ◽

Guillaume Cartron ◽

...

Keyword(s):

Follicular Lymphoma ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Phase 1B ◽

Large B Cell

Download Full-text